HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of plerixafor in patients with Hodgkin lymphoma with poor mobilization of peripheral blood stem cells.

AuthorsShan Yuan, Auayporn Nademanee, Stephen J Forman, Shirong Wang
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 54 Issue 3 Pg. 646-8 (Mar 2013) ISSN: 1029-2403 [Electronic] United States
PMID22812457 (Publication Type: Letter)
Chemical References
  • Antigens, CD34
  • Benzylamines
  • Cyclams
  • Heterocyclic Compounds
  • Granulocyte Colony-Stimulating Factor
  • plerixafor
Topics
  • Adult
  • Aged
  • Antigens, CD34 (blood)
  • Benzylamines
  • Cell Count
  • Cyclams
  • Female
  • Granulocyte Colony-Stimulating Factor (pharmacology)
  • Hematopoietic Stem Cell Mobilization (methods)
  • Hematopoietic Stem Cells (cytology, metabolism)
  • Heterocyclic Compounds (pharmacology)
  • Hodgkin Disease (blood, drug therapy)
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Stem Cell Transplantation (methods)
  • Transplantation, Autologous
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: